EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

Sales Representative, Applied Biosystems